247 related articles for article (PubMed ID: 19124158)
1. Effects of the loss of Atox1 on the cellular pharmacology of cisplatin.
Safaei R; Maktabi MH; Blair BG; Larson CA; Howell SB
J Inorg Biochem; 2009 Mar; 103(3):333-41. PubMed ID: 19124158
[TBL] [Abstract][Full Text] [Related]
2. Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity.
Bompiani KM; Tsai CY; Achatz FP; Liebig JK; Howell SB
Metallomics; 2016 Sep; 8(9):951-62. PubMed ID: 27157188
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
4. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells.
Blair BG; Larson CA; Adams PL; Abada PB; Safaei R; Howell SB
Mol Pharmacol; 2010 Jun; 77(6):912-21. PubMed ID: 20194531
[TBL] [Abstract][Full Text] [Related]
5. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.
Blair BG; Larson CA; Safaei R; Howell SB
Clin Cancer Res; 2009 Jul; 15(13):4312-21. PubMed ID: 19509135
[TBL] [Abstract][Full Text] [Related]
6. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
Howell SB; Safaei R; Larson CA; Sailor MJ
Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
[TBL] [Abstract][Full Text] [Related]
7. Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin.
Huang CP; Fofana M; Chan J; Chang CJ; Howell SB
Metallomics; 2014 Mar; 6(3):654-61. PubMed ID: 24522273
[TBL] [Abstract][Full Text] [Related]
8. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
[TBL] [Abstract][Full Text] [Related]
9. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.
Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801
[TBL] [Abstract][Full Text] [Related]
11. Copper redistribution in Atox1-deficient mouse fibroblast cells.
McRae R; Lai B; Fahrni CJ
J Biol Inorg Chem; 2010 Jan; 15(1):99-105. PubMed ID: 19865834
[TBL] [Abstract][Full Text] [Related]
12. Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila.
Hua H; Günther V; Georgiev O; Schaffner W
Biometals; 2011 Jun; 24(3):445-53. PubMed ID: 21465178
[TBL] [Abstract][Full Text] [Related]
13. Probing the interaction of cisplatin with the human copper chaperone Atox1 by solution and in-cell NMR spectroscopy.
Arnesano F; Banci L; Bertini I; Felli IC; Losacco M; Natile G
J Am Chem Soc; 2011 Nov; 133(45):18361-9. PubMed ID: 21981264
[TBL] [Abstract][Full Text] [Related]
14. Copper accumulation and compartmentalization in mouse fibroblast lacking metallothionein and copper chaperone, Atox1.
Miyayama T; Suzuki KT; Ogra Y
Toxicol Appl Pharmacol; 2009 Jun; 237(2):205-13. PubMed ID: 19362104
[TBL] [Abstract][Full Text] [Related]
15. Ctr1 Intracellular Loop Is Involved in the Copper Transfer Mechanism to the Atox1 Metallochaperone.
Levy AR; Nissim M; Mendelman N; Chill J; Ruthstein S
J Phys Chem B; 2016 Dec; 120(48):12334-12345. PubMed ID: 27934216
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of copper transport at the blood-cerebrospinal fluid barrier: influence of iron deficiency in an in vitro model.
Monnot AD; Zheng G; Zheng W
Exp Biol Med (Maywood); 2012 Mar; 237(3):327-33. PubMed ID: 22442359
[TBL] [Abstract][Full Text] [Related]
17. Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.
Galluzzi L; Marsili S; Vitale I; Senovilla L; Michels J; Garcia P; Vacchelli E; Chatelut E; Castedo M; Kroemer G
Cell Cycle; 2013 Feb; 12(3):417-21. PubMed ID: 23287530
[TBL] [Abstract][Full Text] [Related]
18. Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation.
Itoh S; Kim HW; Nakagawa O; Ozumi K; Lessner SM; Aoki H; Akram K; McKinney RD; Ushio-Fukai M; Fukai T
J Biol Chem; 2008 Apr; 283(14):9157-67. PubMed ID: 18245776
[TBL] [Abstract][Full Text] [Related]
19. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.
Matsumoto S; Tanaka T; Kurokawa H; Matsuno K; Hayashida Y; Takahashi T
Anticancer Res; 2007; 27(4B):2209-16. PubMed ID: 17695505
[TBL] [Abstract][Full Text] [Related]
20. Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function.
Chen GF; Sudhahar V; Youn SW; Das A; Cho J; Kamiya T; Urao N; McKinney RD; Surenkhuu B; Hamakubo T; Iwanari H; Li S; Christman JW; Shantikumar S; Angelini GD; Emanueli C; Ushio-Fukai M; Fukai T
Sci Rep; 2015 Oct; 5():14780. PubMed ID: 26437801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
